Synthetic Immunotherapeutics against Gram-negative Pathogens

Feigman MS, Kim S, Pidgeon S, Yu Y, Ongwae GM, Patel D, Regen S, Im W, Pires M. Synthetic Immunotherapeutics against Gram-negative Pathogens. Cell Chem Biol. 2018;25(10):1185–1194.e5.

Abstract

While traditional drug discovery continues to be an important platform for the search of new antibiotics, alternative approaches should also be pursued to complement these efforts. We herein designed a class of molecules that decorate bacterial cell surfaces with the goal of re-engaging components of the immune system toward Escherichia coli and Pseudomonas aeruginosa. More specifically, conjugates were assembled using polymyxin B (an antibiotic that inherently attaches to the surface of Gram-negative pathogens) and antigenic epitopes that recruit antibodies found in human serum. We established that the spacer length played a significant role in hapten display within the bacterial cell surface, a result that was confirmed both experimentally and via molecular dynamics simulations. Most importantly, we demonstrated the specific killing of bacteria by our agent in the presence of human serum. By enlisting the immune system, these agents have the potential to pave the way for a potent antimicrobial modality.
Last updated on 11/26/2020